EHMT2 and neoplasm: EHMT2 has been proposed to have oncogenic functions and its overexpression in leukemia, gastric, lung, prostate cancer, and alveolar RMS causes silencing of tumor suppressor genes through its H3K9me2 activity (Shankar et al., 2013; Casciello et al., 2015; Bhat et al., 2019).